Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Large Granular Lymphocytic

Explore clinical trials studying Leukemia, Large Granular Lymphocytic. Study availability and eligibility vary by location and protocol.

103 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Large Granular Lymphocytic trial results

Completed

Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

NCT05225584

Conditions
Cutaneous T-cell Lymphoma (CTCL), Hematologic Diseases, Hemic and Lymphatic Diseases, +22 more
Locations
  • UC Irvine Health-Chao Family Comprehensive Cancer Center Orange, California, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Hackensack University Medical Center, John Theurer Cancer Center Hackensack, New Jersey, United States
View all 13 locations
View Trial Details
Completed

CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

NCT02168140

Conditions
Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, +40 more
Locations
  • Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
  • Abramson Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial

NCT00897767

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +42 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
View all 214 locations
View Trial Details
Completed

A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL

NCT03239392

Conditions
CTCL, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The James Cancer Center, Ohio State University Columbus, Ohio, United States
  • University of Virginia Cancer Center Charlottesville, Virginia, United States
View Trial Details

Related conditions